Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-12 Sale |
2021-05-13 4:53 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $27.42 | $111,805 | 168,874 (Direct) |
View |
2021-05-03 Sale |
2021-05-05 4:31 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $26.64 | $66,602 | 166,809 (Direct) |
View |
2021-04-12 Sale |
2021-04-13 8:45 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $25 | $101,950 | 172,952 (Direct) |
View |
2021-04-05 Sale |
2021-04-07 5:17 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $25.54 | $63,848 | 169,309 (Direct) |
View |
2021-03-12 Sale |
2021-03-16 4:56 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $26.36 | $107,493 | 177,030 (Direct) |
View |
2021-03-03 Sale |
2021-03-04 5:52 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $26.1 | $65,262 | 171,809 (Direct) |
View |
2021-02-12 Sale |
2021-02-12 9:24 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $27.23 | $111,025 | 181,108 (Direct) |
View |
2021-02-03 Sale |
2021-02-04 5:47 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $25.35 | $63,375 | 174,309 (Direct) |
View |
2021-01-12 Sale |
2021-01-14 8:57 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
11,578 | $34.03 | $394,041 | 256,437 (Direct) |
View |
2021-01-08 Sale |
2021-01-11 5:59 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.94 | $101,820 | 218,171 (Direct) |
View |
2021-01-04 Sale |
2021-01-06 6:27 pm |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $31.41 | $78,525 | 176,809 (Direct) |
View |
2021-01-04 Sale |
2021-01-06 6:21 pm |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
12,000 | $31.13 | $373,505 | 1,191,685 (Indirect Direct) |
View |
2020-12-14 Sale |
2020-12-16 7:41 pm |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $34.95 | $142,522 | 189,264 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-18 Option Award |
2021-06-22 6:16 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Shah Rajeev M. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:15 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:14 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Mayweg Alexander Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:14 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:13 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | INGRAM ROBERT ALEXANDER Director |
15,000 | $0 | 22,437 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:13 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | INGRAM ROBERT ALEXANDER Director |
1,255 | $12.95 | 22,437 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:13 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-06-18 Option Award |
2021-06-22 6:12 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2021-05-20 Other |
2021-05-21 5:52 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Shah Rajeev M. Director |
443 | $24.01 | 2,590,347 (Direct) |
View |
2021-05-12 Exercise |
2021-05-13 4:53 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 168,874 (Direct) |
View |
2021-05-12 Exercise |
2021-05-13 4:53 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 168,874 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 4:31 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 166,809 (Direct) |
View |
2021-05-03 Exercise |
2021-05-05 4:31 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 166,809 (Direct) |
View |
2021-04-20 Option Award |
2021-04-23 9:14 pm |
N/A 2031-04-19 |
Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director |
14,921 | $0 | 14,921 (Direct) |
View |
2021-04-20 Option Award |
2021-04-23 9:14 pm |
N/A 2031-04-19 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
14,921 | $0 | 14,921 (Direct) |
View |
2021-04-12 Exercise |
2021-04-13 8:45 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 172,952 (Direct) |
View |
2021-04-12 Exercise |
2021-04-13 8:45 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
179,915 | $0 | 172,952 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:17 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 169,309 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:17 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 169,309 (Direct) |
View |
2021-04-01 Other |
2021-04-05 4:34 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Shah Rajeev M. Director |
353,814 | $24.26 | 2,944,161 (Indirect) |
View |
2021-03-18 Option Award |
2021-03-22 8:33 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
547 | $24.01 | 3,449,304 (Direct) |
View |
2021-03-18 Option Award |
2021-03-22 8:25 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Shah Rajeev M. Director |
443 | $24.01 | 2,590,347 (Direct) |
View |
2021-03-18 Option Award |
2021-03-22 8:19 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | INGRAM ROBERT ALEXANDER Director |
677 | $24.01 | 6,182 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 4:56 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 177,030 (Direct) |
View |
2021-03-12 Exercise |
2021-03-16 4:56 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 177,030 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 5:52 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 171,809 (Direct) |
View |
2021-03-03 Exercise |
2021-03-04 5:52 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 171,809 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 7:06 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 7:01 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 6:55 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | HUMPHREY RACHEL Chief Medical Officer |
60,000 | $0 | 60,000 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 6:47 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 6:46 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
225,000 | $0 | 225,000 (Direct) |
View |
2021-02-12 Exercise |
2021-02-12 9:24 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 181,108 (Direct) |
View |
2021-02-12 Exercise |
2021-02-12 9:24 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 181,108 (Direct) |
View |
2021-02-03 Exercise |
2021-02-04 5:47 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 174,309 (Direct) |
View |
2021-02-03 Exercise |
2021-02-04 5:47 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 174,309 (Direct) |
View |
2021-01-19 Option Award |
2021-01-22 4:59 pm |
N/A 2031-01-19 |
Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director |
29,842 | $0 | 29,842 (Direct) |
View |
Ownership |
2021-01-22 4:53 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Dhingra Kapil Director |
0 | $0 | 69,353 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 8:57 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 256,437 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 8:57 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
11,578 | $0 | 256,437 (Direct) |
View |
2021-01-12 Exercise |
2021-01-14 8:57 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
7,500 | $10.86 | 256,437 (Direct) |
View |
2021-01-08 Exercise |
2021-01-11 5:59 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 218,171 (Direct) |
View |
2021-01-08 Exercise |
2021-01-11 5:59 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 218,171 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 6:27 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $0 | 176,809 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 6:27 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
2,500 | $10.86 | 176,809 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 6:21 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $6.42 | 1,191,685 (Direct) |
View |
2021-01-04 Exercise |
2021-01-06 6:21 pm |
N/A 2029-08-13 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
3,000 | $0 | 1,191,685 (Direct) |
View |
2020-12-28 Exercise |
2020-12-29 4:46 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
5,400 | $3.2 | 189,264 (Direct) |
View |
2020-12-28 Exercise |
2020-12-29 4:46 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
5,400 | $0 | 189,264 (Direct) |
View |
2020-12-15 Option Award |
2020-12-16 7:42 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | INGRAM ROBERT ALEXANDER Director |
505 | $34.29 | 5,505 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 7:42 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
3,200 | $0 | 179,309 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 7:42 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Roberts Christopher D. Chief Scientific Officer |
3,200 | $10.86 | 179,309 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 7:41 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $3.2 | 189,264 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 7:41 pm |
N/A 2029-06-11 |
Black Diamond Therapeutics Inc. | BDTX | Hatzis-Schoch Brent See Remarks |
4,078 | $0 | 189,264 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 7:39 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
2,500 | $6.42 | 1,203,685 (Direct) |
View |
2020-12-15 Exercise |
2020-12-16 7:39 pm |
N/A 2029-08-13 |
Black Diamond Therapeutics Inc. | BDTX | Epstein David M. See Remarks |
2,500 | $0 | 1,203,685 (Direct) |
View |
2020-12-14 Other |
2020-12-16 7:04 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner |
21,401 | $0 | 5,628,442 (Indirect) |
View |
2020-12-14 Other |
2020-12-16 6:58 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Bolzon Bradley J PhD Director 10% Owner |
21,412 | $0 | 5,650,304 (Indirect) |
View |